Latest Corporate News
BlackRock-Led Consortium Acquires AES in $10.7 Billion Deal
Global Infrastructure Partners, backed by BlackRock, is buying AES Corporation for $10.7 billion in cash, marking a shift to private ownership for the major clean energy supplier. The deal, at $15 per share, addresses surging US electricity demand from data centers projected to need 176 GW by 2035.
Investors include EQT, CalPERS, and Qatar Investment Authority, with closure expected late 2026.
Devon Energy and Coterra Energy Announce $58 Billion Merger of Equals
Devon Energy and Coterra Energy revealed a $58 billion merger, creating a shale giant amid energy security push. This follows Chevron's moves, fueled by Middle East conflict and AI power demands.
The deal reshapes US energy landscape with focus on onshoring supplies.
Transocean and Valaris Complete $5.8 Billion Offshore Drilling Merger
Transocean Ltd. and Valaris merged for $5.8 billion, intensifying competition in deepwater projects in Guyana and Brazil. The consolidation reflects a 'winner-takes-all' trend for offshore drillers.
It bolsters scale amid global resource scarcity pressures.
Fagron Finalizes Acquisition of Vepakum in Latin America
Fagron completed its purchase of Vepakum, a Brazilian pharmaceutical packaging firm, after regulatory approval. The deal enters a new vertical, promising synergies in packaging and distribution.
It follows announcements of other pending acquisitions like Injeplast and Amber.
VERAXA Biotech Shareholders Approve Merger with Voyager Acquisition Corp
VERAXA Biotech AG shareholders greenlit a merger and new share issuance to Voyager Acquisition Corp on March 2. The biotech firm advances therapies, with the deal poised to accelerate development.
Zurich-based VERAXA focuses on innovative biotech solutions.
Zurich Agrees Terms for All-Cash Acquisition of Beazley
Zurich formalized terms for an all-cash offer to buy Beazley, advancing the insurance sector consolidation. The deal covers entire issued and to-be-issued share capital.
It strengthens Zurich's position amid volatile markets.
Rallybio and Candid Therapeutics Announce Merger
Rallybio Corporation merged with Candid Therapeutics, forming a company advancing T-cell engagers for autoimmune diseases. The combined entity operates as Candid Therapeutics with a strong portfolio.
Wilson Sonsini advised on related patent matters.
TMT Mid-Market M&A Set to Boom in 2026 After Strong 2025
Global TMT M&A value hit $1.6tn in 2025, up 73%, with mid-market deals rising 15% to $239bn. Private equity buyouts grew 24% in value, targeting AI-enabled platforms.
2026 outlook predicts further surge driven by digital transformation.
US M&A Surges to $110 Billion in January 2026 Led by Energy Deals
US mergers hit $110.1 billion across 846 deals in January, ending deal winter amid conflict and AI needs. Energy and utilities dominated, prioritizing scale and security.
FTC faces pressure to approve amid national security claims.
Global Markets Plunge Over 2% on Geopolitical Tensions
Asian and European indices fell over 2%, Brent crude dropped below $80, gold topped $5300 amid Iran conflict fallout. Markets react to US-Israel strikes and Qatar gas halt spiking energy prices.
Safe havens like gold rose as stocks cratered.
European Gas Prices Surge 45% After Qatar Halts Production
Gas prices jumped 45% to 46 euros per MWh after Iranian strikes hit Qatar facilities. This exacerbates supply fears from US-Israel war on Iran.
European markets shed 2% at open, threatening Hormuz shipping.
Oil Prices Spike 8% Initially Amid Supply Concerns
US crude surged 8% early, then retreated, as energy markets brace for escalation. Gold up 2.5%, silver 2% as investors flock to safe assets.
Conflict disrupts global energy supplies via Strait of Hormuz.